Plus Therapeutics, Inc.

NasdaqCM:PSTV 주식 보고서

시가총액: US$8.0m

Plus Therapeutics 대차 대조표 상태

재무 상태 기준 확인 0/6

Plus Therapeutics has a total shareholder equity of $-7.6M and total debt of $3.3M, which brings its debt-to-equity ratio to -43.2%. Its total assets and total liabilities are $11.2M and $18.8M respectively.

주요 정보

-43.2%

부채 비율

US$3.29m

부채

이자 보상 비율n/a
현금US$8.44m
주식-US$7.62m
총 부채US$18.84m
총 자산US$11.21m

최근 재무 상태 업데이트

Recent updates

Plus Therapeutics jumps 18% as JonesTrading adds another Buy rating

Oct 07

Plus Therapeutics finalizes $17.6M grant from Texas, to get initial funds by October end

Sep 22

Plus Therapeutics GAAP EPS of -$0.24 misses by $0.02

Jul 21

재무 상태 분석

단기부채: PSTV has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

장기 부채: PSTV has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


부채 대 자본 내역 및 분석

부채 수준: PSTV has negative shareholder equity, which is a more serious situation than a high debt level.

부채 감소: PSTV's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


대차 대조표


현금 런웨이 분석

과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.

안정적인 현금 활주로: PSTV has less than a year of cash runway based on its current free cash flow.

예측 현금 활주로: PSTV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.1% each year


건강한 기업 발견하기